HOME
|
CAREER opportunities
|
CONTACT US
|
SITEMAP
Overview
Founders
Business Model
Board & Management
Scientific Advisory Board
Contact Us
Corporate Governance
Financial Reports
Analyst Coverage
Press Releases
ASX Announcements
Investor Presentations
Investors Media Centre
German Investors
Request Information
Partnering
Licensing
Competitive Position
Phylomer Libraries
Intellectual Property
Publications
Intracellular
Extracellular/CD40L
Antimicrobial
Current Partners
Corporate Governance
Financial Reports
Analyst Coverage
Press Releases
ASX Announcements
Investor Presentations
Investors Media Centre
German Investors
Request Information
2010
2009
2008
2007
2006
2005
Announcement Title
Date
Preliminary Final Report
31-08-2010
Amended Appendix 3B Rights Issue
31-08-2010
Renounceable Issue Prospectus
29-08-2010
Renounceable Issue Shareholder Letter
29-08-2010
Renounceable Issue Optionholder Letter
29-08-2010
Rights Issue prelim Appendix 3B
26-08-2010
Fully Underwritten Renouncable Rights Issue
26-08-2010
RB Milestone Report Aug 2010
23-08-2010
Bioshares CEO Interview P Watt
19-08-2010
Finance News Network Interview with Director Nick Woolf
19-08-2010
Phylogica enters into an alliance with AstraZeneca to discover new antimicrobials to combat multi-re
18-08-2010
Medimmune Announcement
18-08-2010
Reinstatement of Official Quotation
17-08-2010
Agreement Update
16-08-2010
Response to ASX Query - Appendix 4C
08-08-2010
1
2
3
>
© 2009 Phylogica | ABN 48 098 391 961 |
Privacy Statement
Last updated: 09/06/2009 | Website by
Harmonic New Media
